Patent · US Active

Anti IL-34 antibodies

US10703813B2 · kind B2 · utility

2Cited by

13References

17Claims

0Family size

Assignees

UNIVERSITE DE NANTES · FR
CHU NANTES · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Dominique Heymann · Indre, FR
Aude Segaliny · Laguna Hills, US
Régis Brion · Chantonnay, FR

Key dates

Filing date	Dec 21, 2015
Grant date	Jul 7, 2020
Priority date	—
Expiry date	Dec 21, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/54
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to novel anti IL-34 antibodies or antigen-binding fragments thereof specifically binding cytokine IL-34 with high affinity, the method of obtaining of these antibodies and their therapeutic use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.